ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "physician data and rheumatoid arthritis (RA)"

  • Abstract Number: 126 • 2015 ACR/ARHP Annual Meeting

    Patients with Osteoarthritis and Rheumatoid Arthritis Seen at 4 Different Routine Rheumatology Care Sites at This Time Have Similar and Patient and Physician Global Estimates of Severity, and Scores for Functional Disability, Pain, and RAPID3

    Carlos El-Haddad1, Isabel Castrejón2, Kathryn A. Gibson3, Yusuf Yazici4, Martin Bergman5 and Theodore Pincus2, 1Rheumatology, Liverpool Hospital, NSW, Australia, 2Rheumatology, Rush University Medical Center, Chicago, IL, 3Liverpool Hospital, Liverpool, Australia, 4NYU Hospital for Joint Diseases, New York, NY, 5Division of Rheumatology, Taylor Hospital, Ridley Park, PA

    Background/Purpose: RA generally is regarded by physicians and the public as a more severe problem than OA. However, OA has been ranked as the 11th…
  • Abstract Number: 135 • 2015 ACR/ARHP Annual Meeting

    Limitations of Treat-to-Target in Rheumatoid Arthritis: Joint Damage Appears As Severe As Inflammation in Contemporary Care at One Site

    Theodore Pincus1, Alex D. Luta2, Isabel Castrejón1, Annie Huang1, Ruchi Jain1, Sarah L. Everakes3 and Joel A. Block4, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Georgetown University, Washington, DC, 3Internal Medicine, Rush University Medical Center, Chicago, IL, 4Rush University Medical Center, Chicago, IL

    Background/Purpose: Treatment of rheumatoid arthritis is directed to “treat-to-target,” with intensification of therapy in patients with moderate/high disease activity according to a quantitative index toward…
  • Abstract Number: 2325 • 2015 ACR/ARHP Annual Meeting

    Quantitative Clues to Recognize and Document Comorbid Fibromyalgia in Routine Care of Patients with Other Rheumatic Diagnoses on a 10 Cm Distress Visual Analog Scale Found on 1-Page Physician Rheumetric Checklist

    Kathryn A. Gibson1, Katherine J. Bryant2 and Theodore Pincus3, 1Liverpool Hospital, Liverpool, Australia, 2University of New South Wales, Sydney, Australia, 3Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: A physician global estimate (DOCGL) is commonly used to assess patients with rheumatic diseases. Fibromyalgia (FM) has been reported as a comorbidity in 10-35%…
  • Abstract Number: 2335 • 2015 ACR/ARHP Annual Meeting

    How Much Does Fatigue Contribute to the Physician and Patient Global Estimates in Different Rheumatic Diseases? Analysis from Routine Care on a Multidimensional Health Assessment Questionnaire (MDHAQ)

    Isabel Castrejón1, Elena Nikiphorou2, Ruchi Jain1, Annie Huang1, Joel A. Block3 and Theodore Pincus1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Rheumatology, Addenbrooke's Hospital, Cambridge, United Kingdom, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: Fatigue is an important problem for many patients with rheumatic diseases. Fatigue is associated with disease severity, psychological distress, and a poorer quality of…
  • Abstract Number: 2672 • 2015 ACR/ARHP Annual Meeting

    Determinants of Patient- Physician Discordance in Assessment of Global Disease Activity in Latinos with Rheumatoid Arthritis in the United States

    George A. Karpouzas1, Taylor Draper2, Elizabeth Hernandez1 and Sarah Ormseth1, 1Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 2Psychology, Loma Linda University, Loma Linda, CA

    Background/Purpose: Patients and physicians often differ in their perceptions of disease activity in Rheumatoid arthritis (RA) as described by patients' and evaluators' global assessments (PGA…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology